| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cabb87bffb01001b48b06ecad598edbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d30fabb645f120791a4304ba1f5b6e9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2fb994e4feabd1262e8f88ba11c0c9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82627a102725bc348e6868510bd82972 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate |
2005-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8c2adf700a87f60378d64216ce99634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d37a1ef89b2829c087e3a4d991b69982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c77e1c63482af10f9410b400707bd5cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc0a093dbaa152a4f37aaf5f55c303b6 |
| publicationDate |
2006-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006106109-A1 |
| titleOfInvention |
Short term treatment for uterine disorder |
| abstract |
This invention is directed to a method and device for treating a female patient's uterine disorder by occluding one or both of the patient's uterine artery. The treatment embodying features of the invention basically involves occluding one or both of the patient's uterine arteries with an intravaginal device to form a thrombus within the occluded artery or arteries and administering an agent which will prolong the occlusion of the artery or arteries after removal of the occluding device or initiate or accelerate fibroid cell apoptosis (programmed cell death). The intravaginal device has a pair of pivotally connected occluding members, with at least one of the occluding member having a movable occluding element on a distal shaft section of the occluding member. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009062827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018256181-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011022073-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009054915-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009054916-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010130815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010100195-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8145321-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11134969-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8403953-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009318950-A1 |
| priorityDate |
2004-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |